Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Awaiting price reaction for this filing.
J.B. Chemicals & Pharmaceuticals has approved the acquisition of up to 70 lakh equity shares (not exceeding 4% stake) of Jamnagar Renewables One Private Limited (JROPL) from Continuum Green Energy Limited, for a total investment of up to Rs. 7 crore. JROPL is a new special purpose vehicle (SPV) that will set up a 48.60 MW wind-solar hybrid power project in Jamnagar, Gujarat. The investment is aimed at helping JB Chemicals source renewable power through a group captive arrangement, reduce carbon emissions, and meet its ESG commitments. The deal is a cash transaction, not a related party deal, requires no regulatory approvals, and is expected to be completed by September 30, 2025.
This is a small strategic investment (Rs. 7 crore, 4% stake) in a renewable energy SPV, unlikely to materially impact financials but supports the company's long-term ESG goals and may help reduce power costs over time. Shareholders are unlikely to see an immediate effect on stock price.